The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
IgA: Structure, Function, and Developability
Open accessAbstract
Immunoglobulin A (IgA) plays a key role in defending mucosal surfaces against attack by infectious microorganisms. Such sites present a major site of susceptibility due to their vast surface area and their constant exposure to ingested and inhaled material. The importance of IgA to effective immune defence is signalled by the fact that more IgA is produced than all the other immunoglobulin classes combined. Indeed, IgA is not just the most prevalent antibody class at mucosal sites, but is also present at significant concentrations in serum. The unique structural features of the IgA heavy chain allow IgA to polymerise, resulting in mainly dimeric forms, along with some higher polymers, in secretions. Both serum IgA, which is principally monomeric, and secretory forms of IgA are capable of neutralising and removing pathogens through a range of mechanisms, including triggering the IgA Fc receptor known as FcαRI or CD89 on phagocytes. The effectiveness of these elimination processes is highlighted by the fact that various pathogens have evolved mechanisms to thwart such IgA-mediated clearance. As the structure–function relationships governing the varied capabilities of this immunoglobulin class come into increasingly clear focus, and means to circumvent any inherent limitations are developed, IgA-based monoclonal antibodies are set to emerge as new and potent options in the therapeutic arena.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Neutrophil Function: From Mechanisms to Disease
Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D., & Zychlinsky, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074942 · Cited by 1,708
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Weiner, L. M., Surana, R., & Wang, S. (2010) · Nature Reviews Immunology · doi:10.1038/nri2744 · Cited by 1,283
Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut
Mantis, N. J., Rol, N., & Corthésy, B. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.41 · Cited by 1,283
Mucosal vaccines: the promise and the challenge
Neutra, M. R., & Kozlowski, P. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1777 · Cited by 1,223
Benvenuti, S., Sartore-Bianchi, A., Di Nicolantonio, F., Zanon, C., Moroni, M., Veronese, S., Siena, S., & Bardelli, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4158 · Cited by 830
Kaetzel, C. S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00278.x · Cited by 582
Mouse and human FcR effector functions
Bruhns, P., & Jönsson, F. (2015) · Immunological Reviews · doi:10.1111/imr.12350 · Cited by 579
Phosphocholine binding immunoglobulin Fab McPC603
Satow, Y., Cohen, G. H., Padlan, E. A., & Davies, D. R. (1986) · Journal of Molecular Biology · doi:10.1016/0022-2836(86)90245-7 · Cited by 568
Mechanisms of killing by anti-CD20 monoclonal antibodies
Glennie, M. J., French, R. R., Cragg, M. S., & Taylor, R. P. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.151 · Cited by 515
Burns, J. W., Siadat-Pajouh, M., Krishnaney, A. A., & Greenberg, H. B. (1996) · Science · doi:10.1126/science.272.5258.104 · Cited by 493
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Dumont, J., Euwart, D., Mei, B., Estes, S., & Kshirsagar, R. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1084266 · Cited by 483
Intracellular neutralization of virus by immunoglobulin A antibodies.
Mazanec, M. B., Kaetzel, C. S., Lamm, M. E., Fletcher, D., & Nedrud, J. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6901 · Cited by 440
Clements, M. L., Betts, R. F., Tierney, E. L., & Murphy, B. R. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.24.1.157-160.1986 · Cited by 435
Kaplon, H., & Reichert, J. M. (2019) · mAbs · doi:10.1080/19420862.2018.1556465 · Cited by 434
Human IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway
Roos, A., Bouwman, L. H., van Gijlswijk-Janssen, D. J., Faber-Krol, M. C., Stahl, G. L., & Daha, M. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2861 · Cited by 431
Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract
Renegar, K. B., Small, P. A., Boykins, L. G., & Wright, P. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1978 · Cited by 423
Zhang, J.-R., Mostov, K. E., Lamm, M. E., Nanno, M., Shimida, S.-I., Ohwaki, M., & Tuomanen, E. (2000) · Cell · doi:10.1016/s0092-8674(00)00071-4 · Cited by 419
Mattu, T. S., Pleass, R. J., Willis, A. C., Kilian, M., Wormald, M. R., Lellouch, A. C., Rudd, P. M., Woof, J. M., & Dwek, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2260 · Cited by 404
Self-citationMonoclonal Antibodies for Cancer Therapy
(2012) · SpringerReference · doi:10.1007/springerreference_303431 · Cited by 393
Human antibody–Fc receptor interactions illuminated by crystal structures
Woof, J. M., & Burton, D. R. (2004) · Nature Reviews Immunology · doi:10.1038/nri1266 · Cited by 387
Self-citationIntravascular and Mucosal Immunoglobulin A: Two Separate but Related Systems of Immune Defense?
CONLEY, M. E., & DELACROIX, D. L. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-892 · Cited by 375
Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation
Pasquier, B., Launay, P., Kanamaru, Y., Moura, I. C., Pfirsch, S., Ruffié, C., Hénin, D., Benhamou, M., Pretolani, M., Blank, U., et al. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.017 · Cited by 346
Secretory IgA N- and O-Glycans Provide a Link between the Innate and Adaptive Immune Systems
Royle, L., Roos, A., Harvey, D. J., Wormald, M. R., Van Gijlswijk-Janssen, D., Redwan, E.-R. M., Wilson, I. A., Daha, M. R., Dwek, R. A., & Rudd, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301436200 · Cited by 335
Passive transfer of local immunity to influenza virus infection by IgA antibody
Renegar, K. B., & Small, P. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.6.1972 · Cited by 322
Role of J Chain in Secretory Immunoglobulin Formation
Johansen, Braathen, & Brandtzaeg (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00790.x · Cited by 322
Colombo, M. P., Ferrari, G., Stoppacciaro, A., Parenza, M., Rodolfo, M., Mavilio, F., & Parmiani, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.889 · Cited by 313
Matysiak-Budnik, T., Moura, I. C., Arcos-Fajardo, M., Lebreton, C., Ménard, S., Candalh, C., Ben-Khalifa, K., Dugave, C., Tamouza, H., van Niel, G., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071204 · Cited by 313
Mazanec, M. B., Coudret, C. L., & Fletcher, D. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1339-1343.1995 · Cited by 295
Bispecific antibodies: design, therapy, perspectives
Sedykh, S., Prinz, V., Buneva, V., & Nevinsky, G. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s151282 · Cited by 292
Ben Mkaddem, S., Benhamou, M., & Monteiro, R. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00811 · Cited by 283
Wold, A. E., Mestecky, J., Tomana, M., Kobata, A., Ohbayashi, H., Endo, T., & Edén, C. S. (1990) · Infection and Immunity · doi:10.1128/iai.58.9.3073-3077.1990 · Cited by 282
Hatjiharissi, E., Xu, L., Santos, D. D., Hunter, Z. R., Ciccarelli, B. T., Verselis, S., Modica, M., Cao, Y., Manning, R. J., Leleu, X., et al. (2007) · Blood · doi:10.1182/blood-2007-01-070656 · Cited by 282
Herr, A. B., Ballister, E. R., & Bjorkman, P. J. (2003) · Nature · doi:10.1038/nature01685 · Cited by 274
The human IgA system: A reassessment
Mestecky, J., Russell, M. W., Jackson, S., & Brown, T. A. (1986) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(86)90073-5 · Cited by 259
Launay, P., Grossetête, B., Arcos-Fajardo, M., Gaudin, E., Torres, S. P., Beaudoin, L., Patey-Mariaud de Serre, N., Lehuen, A., & Monteiro, R. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1999 · Cited by 254
FcαRI-positive liver Kupffer cells: Reappraisal of the function of immunoglobulin A in immunity
van Egmond, M., van Garderen, E., van Spriel, A. B., Damen, C. A., van Amersfoort, E. S., van Zandbergen, G., van Hattum, J., Kuiper, J., & van de Winkel, J. G. J. (2000) · Nature Medicine · doi:10.1038/76261 · Cited by 240
IgA and FcαRI: Pathological Roles and Therapeutic Opportunities
Breedveld, A., & van Egmond, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00553 · Cited by 237
Antibodies, Fc receptors and cancer
Nimmerjahn, F., & Ravetch, J. V. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.005 · Cited by 234
Boehm, M. K., Woof, J. M., Kerr, M. A., & Perkins, S. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2556 · Cited by 233
Self-citationThe IgA system: a comparison of structure and function in different species
Snoeck, V., Peters, I. R., & Cox, E. (2006) · Veterinary Research · doi:10.1051/vetres:2006010 · Cited by 212
The J Chain Is Essential for Polymeric Ig Receptor-Mediated Epithelial Transport of IgA
Johansen, F.-E., Braathen, R., & Brandtzaeg, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5185 · Cited by 206
Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens
Biesbrock, A. R., Reddy, M. S., & Levine, M. J. (1991) · Infection and Immunity · doi:10.1128/iai.59.10.3492-3497.1991 · Cited by 197
Rochereau, N., Drocourt, D., Perouzel, E., Pavot, V., Redelinghuys, P., Brown, G. D., Tiraby, G., Roblin, X., Verrier, B., Genin, C., et al. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001658 · Cited by 193
Hernandez‐Ilizaliturri, F. J., Jupudy, V., Ostberg, J. R., Oflazoglu, E., Huberman, A., Repasky, E. A., & Czuczman, M. S. (2003) · PubMed · Cited by 188
A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis
Balu, S., Reljic, R., Lewis, M. J., Pleass, R. J., McIntosh, R., van Kooten, C., van Egmond, M., Challacombe, S., Woof, J. M., & Ivanyi, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003189 · Cited by 184
Self-citationTherapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
Marshall, M. J. E., Stopforth, R. J., & Cragg, M. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01245 · Cited by 183
Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs
Williams, A., Reljic, R., Naylor, I., Clark, S. O., Falero‐Diaz, G., Singh, M., Challacombe, S., Marsh, P. D., & Ivanyi, J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01809.x · Cited by 182
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6–specific IgA mAb
Feng, N., Lawton, J. A., Gilbert, J., Kuklin, N., Vo, P., Prasad, B. V. V., & Greenberg, H. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14397 · Cited by 181
The galactan‐binding immunoglobulin Fab J539: An x‐ray diffraction study at 2.6‐Å resolution
Suh, S. W., Bhat, T. N., Navia, M. A., Cohen, G. H., Rao, D. N., Rudikoff, S., & Davies, D. R. (1986) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340010112 · Cited by 173
Fernandez, M. I., Pedron, T., Tournebize, R., Olivo-Marin, J.-C., Sansonetti, P. J., & Phalipon, A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00122-5 · Cited by 171
Rifai, A., Fadden, K., Morrison, S. L., & Chintalacharuvu, K. R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.12.2171 · Cited by 169
Brandsma, A. M., Bondza, S., Evers, M., Koutstaal, R. W., Nederend, M., Jansen, J. H. M., Rösner, T., Valerius, T., Leusen, J. H. W., & ten Broeke, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00704 · Cited by 157
Immature Neutrophils Mediate Tumor Cell Killing via IgA but Not IgG Fc Receptors
Otten, M. A., Rudolph, E., Dechant, M., Tuk, C. W., Reijmers, R. M., Beelen, R. H. J., van de Winkel, J. G. J., & van Egmond, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5472 · Cited by 155
Tamura, S., Funato, H., Hirabayashi, Y., Suzuki, V., Nagamine, T., Aizawa, C., & Kurata, T. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210602 · Cited by 153
A simple, robust and highly efficient transient expression system for producing antibodies
Vink, T., Oudshoorn-Dickmann, M., Roza, M., Reitsma, J.-J., & de Jong, R. N. (2013) · Methods · doi:10.1016/j.ymeth.2013.07.018 · Cited by 152
Extensive sequence homology between IgA receptor and M proteins in Streptococcus pyogenes
Frithz, E., Heden, L. O., & Lindahl, G. (1989) · Molecular Microbiology · doi:10.1111/j.1365-2958.1989.tb00261.x · Cited by 150
Herremans, T. M. P. T., Reimerink, J. H. J., Buisman, A. M., Kimman, T. G., & Koopmans, M. P. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.5011 · Cited by 149
A Mucosal IgA-Mediated Excretory Immune System In Vivo
Robinson, J., Blanchard, T. G., Levine, A. D., Emancipator, S. N., & Lamm, M. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3688 · Cited by 147
Ig Constant Region Effects on Variable Region Structure and Function
Markmann, A. J., Bowen, A. D., Greenspan, N. S., & Casadevall, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00022 · Cited by 145
Aleyd, E., van Hout, M. W. M., Ganzevles, S. H., Hoeben, K. A., Everts, V. E., Bakema, J. E., & van Egmond, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300261 · Cited by 144
Hammerschmidt, S., Tillig, M. P., Wolff, S., Vaerman, J., & Chhatwal, G. S. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01897.x · Cited by 141
The era of the immunoglobulin A Fc receptor Fcα RI ; its function and potential as target in disease
Aleyd, E., Heineke, M. H., & van Egmond, M. (2015) · Immunological Reviews · doi:10.1111/imr.12337 · Cited by 137
Putnam, F. W., Liu, Y., & Low, T. L. K. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30153-9 · Cited by 134
Cutting Edge: Human FcRL4 and FcRL5 Are Receptors for IgA and IgG
Wilson, T. J., Fuchs, A. G., & Colonna, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102651 · Cited by 134
Hedén, L. O., Frithz, E., & Lindahl, G. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210623 · Cited by 133
Vidarsson, G., van der Pol, W. L., van den Elsen, J. M. H., Vilé, H. A., Jansen, M., Duijs, J. M. G. J., Morton, H. C., Boel, E. C. H., Daha, M. R., Corthésy, B., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6250 · Cited by 131
Corthésy, B., Bénureau, Y., Perrier, C., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00927-06 · Cited by 129
Watkins, J. D., Sholukh, A. M., Mukhtar, M. M., Siddappa, N. B., Lakhashe, S. K., Kim, M., Reinherz, E. L., Gupta, S., Forthal, D. N., Sattentau, Q. J., et al. (2013) · AIDS · doi:10.1097/qad.0b013e328360eac6 · Cited by 123
IgA, IgA Receptors, and Their Anti-inflammatory Properties
Mkaddem, S. B., Christou, I., Rossato, E., Berthelot, L., Lehuen, A., & Monteiro, R. C. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_10 · Cited by 122
Pleass, R. J., Areschoug, T., Lindahl, G., & Woof, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009396200 · Cited by 122
Self-citationStockmeyer, B., Dechant, M., van Egmond, M., Tutt, A. L., Sundarapandiyan, K., Graziano, R. F., Repp, R., Kalden, J. R., Gramatzki, M., Glennie, M. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5954 · Cited by 121
Elm, C., Braathen, R., Bergmann, S., Frank, R., Vaerman, J., Kaetzel, C. S., Chhatwal, G. S., Johansen, F., & Hammerschmidt, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310528200 · Cited by 118
Lamkhioued, B., GOUNNI, A. S., Gruart, V., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250121 · Cited by 118
IgA EGFR antibodies mediate tumour killing in vivo
Boross, P., Lohse, S., Nederend, M., Jansen, J. H. M., van Tetering, G., Dechant, M., Peipp, M., Royle, L., Liew, L. P., Boon, L., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201929 · Cited by 118
Immunoglobulin A-Mediated Protection againstBordetella pertussisInfection
Hellwig, S. M. M., van Spriel, A. B., Schellekens, J. F. P., Mooi, F. R., & van de Winkel, J. G. J. (2001) · Infection and Immunity · doi:10.1128/iai.69.8.4846-4850.2001 · Cited by 117
Immunoglobulin metabolism in ataxia telangiectasia
Strober, W., Wochner, R. D., Barlow, M. H., McFarlin, D. E., & Waldmann, T. A. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105881 · Cited by 114
Aleyd, E., Al, M., Tuk, C. W., van der Laken, C. J., & van Egmond, M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502353 · Cited by 114
Bachovchin, W. W., Plaut, A. G., Flentke, G. R., Lynch, M., & Kettner, C. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39656-5 · Cited by 110
Ramsland, P. A., Willoughby, N., Trist, H. M., Farrugia, W., Hogarth, P. M., Fraser, J. D., & Wines, B. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706028104 · Cited by 110
Furtado, P. B., Whitty, P. W., Robertson, A. N., et al. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.03.007 · Cited by 109
Pleass, R. J., Dunlop, J. I., Anderson, C. M., & Woof, J. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23508 · Cited by 107
Self-citationHamburger, A. E., West, A. P., & Björkman, P. J. (2004) · Structure · doi:10.1016/j.str.2004.09.006 · Cited by 106
Stenberg, L., O’Toole, P. W., Mestecky, J. F., & Lindahl, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36854-0 · Cited by 104
Roux, K. H., Strelets, L., Brekke, O. H., Sandlie, I., & Michaelsen, T. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4083 · Cited by 102
Tenovuo, J. O., Moldoveanu, Z., Mestecky, J., Pruitt, K. M., & Rahemtulla, B. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.2.726 · Cited by 101
Field, M. C., Amatayakul‐Chantler, S., Rademacher, T. W., Rudd, P. M., & Dwek, R. A. (1994) · Biochemical Journal · doi:10.1042/bj2990261 · Cited by 100
Pneumococcal IgA1 protease subverts specific protection by human IgA1
Janoff, E. N., Rubins, J. B., Fasching, C., Charboneau, D., Rahkola, J. T., Plaut, A. G., & Weiser, J. N. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.41 · Cited by 98
THE THREE‐DIMENSIONAL CONFORMATION OF γ M and γ A GLOBULIN MOLECULES
Feinstein, A., Munn, E. A., & Richardson, N. E. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb13526.x · Cited by 98
Carayannopoulos, L. N., Hexham, J. M., & Capra, J. D. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1579 · Cited by 98
Stadtmueller, B. M., Huey‐Tubman, K. E., López, C. J., Yang, Z., Hubbell, W. L., & Björkman, P. J. (2016) · eLife · doi:10.7554/elife.10640 · Cited by 98
Wines, B. D., Hulett, M. D., Jamieson, G. P., et al. (1999) · PubMed · Cited by 97
Bakema, J. E., & van Egmond, M. (2011) · mAbs · doi:10.4161/mabs.3.4.16092 · Cited by 96
Effector Mechanisms of Recombinant IgA Antibodies against Epidermal Growth Factor Receptor
Dechant, M., Beyer, T. D., Schneider‐Merck, T., Weisner, W., Peipp, M., van de Winkel, J. G. J., & Valerius, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2936 · Cited by 96
Secretory-IgA Antibodies Play an Important Role in the Immunity to Streptococcus pneumoniae
Fukuyama, Y., King, J. D., Kataoka, K., Kobayashi, R., Gilbert, R. S., Oishi, K., Hollingshead, S. K., Briles, D. E., & Fujihashi, K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000831 · Cited by 92
Xiong, E., Li, Y., Min, Q., Cui, C., Liu, J., Hong, R., Lai, N., Wang, Y., Sun, J., Matsumoto, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904204116 · Cited by 91
Concerted evolution of the primate immunoglobulin alpha-gene through gene conversion.
Kawamura, S., Saitou, N., & Ueda, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42525-2 · Cited by 90
Wines, B. D., Hulett, M. D., Jamieson, G. P., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2146 · Cited by 89
Repp, R., van Ojik, H. H., Valerius, T., Groenewegen, G., Wieland, G., Oetzel, C., Stockmeyer, B., Becker, W., Eisenhut, M., Steininger, H., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601367 · Cited by 88
Immunoglobulin A: FcαRI Interactions Induce Neutrophil Migration Through Release of Leukotriene B4
van der Steen, L. P. E., Tuk, C. W., Bakema, J. E., Kooij, G., Reijerkerk, A., Vidarsson, G., Bouma, G., Kraal, G., de Vries, H. E., Beelen, R. H. J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.047 · Cited by 88
Approved monoclonal antibodies for cancer therapy
Boyiadzis, M. M., & Foon, K. A. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.8.1151 · Cited by 87
Kanamaru, Y., Pfirsch, S., Aloulou, M., Vrtovsnik, F., Essig, M., Loirat, C., Deschênes, G., Guérin-Marchand, C., Blank, U., & Monteiro, R. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2669 · Cited by 86
Recognition of secretory IgA by DC-SIGN: Implications for immune surveillance in the intestine
Baumann, J., Park, C. G., & Mantis, N. J. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.03.005 · Cited by 84
Glycosylation of Human IgA Directly Inhibits Influenza A and Other Sialic-Acid-Binding Viruses
Maurer, M., Meyer, L., Bianchi, M., Turner, H. L., Le, N. P. L., Steck, M., Wyrzucki, A., Orlowski, V., Ward, A. B., Crispin, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.027 · Cited by 84
Analysis of IgA1 N -Glycosylation and Its Contribution to FcαRI Binding
Gomes, M. M., Wall, S. B., Takahashi, K., Novák, J., Renfrow, M. B., & Herr, A. B. (2008) · Biochemistry · doi:10.1021/bi801185b · Cited by 82
Targeting FcαRI on Polymorphonuclear Cells Induces Tumor Cell Killing through Autophagy
Bakema, J. E., Ganzevles, S. H., Fluitsma, D. M., Schilham, M. W., Beelen, R. H. J., Valerius, T., Lohse, S., Glennie, M. J., Medema, J. P., & van Egmond, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002581 · Cited by 82
Schroten, H., Stapper, C., Plogmann, R., Köhler, H., Hacker, J. H., & Hanisch, F. (1998) · Infection and Immunity · doi:10.1128/iai.66.8.3971-3973.1998 · Cited by 81
Lohse, S., Meyer, S., Meulenbroek, L. A. P. M., Jansen, J. H. M., Nederend, M., Kretschmer, A., Klausz, K., Möginger, U., Derer, S., Rösner, T., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1232 · Cited by 81
Mac-1 (CD11b/CD18) as Accessory Molecule for FcαR (CD89) Binding of IgA
van Spriel, A. B., Leusen, J. H. W., Vilé, H. A., & van de Winkel, J. G. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3831 · Cited by 80
Role of Immunoglobulin A in Protection against Reovirus Entry into Murine Peyer's Patches
Silvey, K. J., Hutchings, A. B., Vajdy, M., Petzke, M. M., & Neutra, M. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10870-10879.2001 · Cited by 78
Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly
Atkin, J. D., Pleass, R. J., Owens, R. J., & Woof, J. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.156 · Cited by 75
Self-citationNatvig, I. B., Johansen, F., Nordeng, T. W., Haraldsen, G., & Brandtzaeg, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.9.4330 · Cited by 75
Active-Site Gating Regulates Substrate Selectivity in a Chymotrypsin-Like Serine Protease
Johnson, T. A., Qiu, J., Plaut, A. G., & Holyoak, T. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.041 · Cited by 74
van Spriel, A. B., van den Herik–Oudijk, I. E., van Sorge, N. M., Vilé, H. A., van Strijp, J. A. G., & van de Winkel, J. G. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314643 · Cited by 72
Saito, S., Sano, K., Suzuki, T., Ainai, A., Taga, Y., Ueno, T., Tabata, K., Saito, K., Wada, Y., Ohara, Y., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007427 · Cited by 72
Coyne, R. S., Siebrecht, M. S., Peitsch, M. C., & Casanova, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31739-3 · Cited by 71
Disulfide bond assignment in human J chain and its covalent pairing with immunoglobulin M
Frutiger, S., Hughes, G. J., Paquet, N., Luethy, R., & Jaton, J. C. (1992) · Biochemistry · doi:10.1021/bi00165a014 · Cited by 71
Transient Glyco-Engineering to Produce Recombinant IgA1 with Defined N- and O-Glycans in Plants
Dicker, M., Tschofen, M., Maresch, D., König-Beihammer, J., Juárez, P., Orzáez, D., Altmann, F., Steinkellner, H., & Strasser, R. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00018 · Cited by 70
Mantis, N. J., McGuinness, C. R., Sonuyi, O., Edwards, G., & Farrant, S. A. (2006) · Infection and Immunity · doi:10.1128/iai.02088-05 · Cited by 68
Duchez, S., Amin, R., Cogné, N., Delpy, L., Sirac, C., Pascal, V., Corthésy, B., & Cogné, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912393107 · Cited by 65
Production, characterization, andin vivohalf-life extension of polymeric IgA molecules in mice
Lombana, T. N., Rajan, S., Zorn, J. A., Mandikian, D., Chen, E. C., Estevez, A., Yip, V., Bravo, D. D., Phung, W., Farahi, F., et al. (2019) · mAbs · doi:10.1080/19420862.2019.1622940 · Cited by 64
β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells
Molyneux, K., Wimbury, D. H., Pawluczyk, I. Z. A., Muto, M., Bhachu, J. S., Mertens, P. R., Feehally, J., & Barratt, J. (2017) · Kidney International · doi:10.1016/j.kint.2017.05.002 · Cited by 63
Braathen, R., Sørensen, V., Brandtzæg, P., Sandlie, I., & Johansen, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205502200 · Cited by 62
Krugmann, S., Pleass, R. J., Atkin, J. D., & Woof, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.244 · Cited by 59
Self-citationvan der Bij, G. J., Bögels, M., Otten, M. A., Oosterling, S. J., Kuppen, P. J. K., Meijer, S., Beelen, R. H. J., & van Egmond, M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.023 · Cited by 59
Leusen, J. H. W. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.09.005 · Cited by 59
A Human Immunoglobulin (Ig)A Cα3 Domain Motif Directs Polymeric Ig Receptor–mediated Secretion
Hexham, J. M., White, K. D., Carayannopoulos, L. N., Mandecki, W., Brisette, R., Yang, Y.-S., & Capra, J. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.747 · Cited by 58
van der Pol, W. L., Vidarsson, G., Vilé, H. A., van de Winkel, J. G. J., & Rodrı́guez, M. E. (2000) · The Journal of Infectious Diseases · doi:10.1086/315825 · Cited by 58
Meyer, S., Nederend, M., Jansen, J. H. M., Reiding, K. R., Jacobino, S. R., Meeldijk, J., Bovenschen, N., Wuhrer, M., Valerius, T., Ubink, R., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1106658 · Cited by 58
Rossato, E., Mkaddem, S. B., Kanamaru, Y., Hurtado-Nédelec, M., Hayem, G., Descatoire, V., Vonarburg, C., Miescher, S., Zuercher, A. W., & Monteiro, R. C. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39142 · Cited by 57
Exploring Site-Specific N-Glycosylation of HEK293 and Plant-Produced Human IgA Isotypes
Göritzer, K., Maresch, D., Altmann, F., Obinger, C., & Strasser, R. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00121 · Cited by 57
Chintalacharuvu, K. R., Chuang, P. D., Dragoman, A., Fernandez, C. Z., Qiu, J., Plaut, A. G., Trinh, K. R., Gala, F. A., & Morrison, S. L. (2003) · Infection and Immunity · doi:10.1128/iai.71.5.2563-2570.2003 · Cited by 56
Pullarkat, V., Deo, Y., Link, J., Spears, L., Marty, V., Curnow, R., Groshen, S., Gee, C., & Weber, J. S. (1999) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050543 · Cited by 55
FcαRI (CD89) Alleles Determine the Proinflammatory Potential of Serum IgA
Wu, J., Ji, C., Xie, F., Langefeld, C. D., Qian, K., Gibson, A., Edberg, J. C., & Kimberly, R. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3973 · Cited by 54
Senior, B. W., & Woof, J. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7792 · Cited by 54
Self-citationRecognition of immunoglobulin A1 by oral actinomyces and streptococcal lectins
Rühl, S., Sandberg, A. L., Cole, M. F., & Cisar, J. O. (1996) · Infection and Immunity · doi:10.1128/iai.64.12.5421-5424.1996 · Cited by 53
Structural requirements for the interaction of human IgM and IgA with the human Fcα/μ receptor
Ghumra, A., Shi, J., McIntosh, R. S., Rasmussen, I. B., Braathen, R., Johansen, F., Sandlie, I., Mongini, P. K. A., Areschoug, T., Lindahl, G., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200839184 · Cited by 52
Self-citationBatten, M. R., Senior, B. W., Kilian, M., & Woof, J. M. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1462-1469.2003 · Cited by 51
Self-citationLamm, M. E., Emancipator, S. N., Robinson, J., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070131 · Cited by 50
Bioley, G., Monnerat, J., Lötscher, M., Vonarburg, C., Zuercher, A. W., & Corthésy, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01043 · Cited by 50
Monoclonal antibody‐mediated killing of tumour cells by neutrophils
Heemskerk, N., & van Egmond, M. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12962 · Cited by 50
Structural Requirements for the Interaction of Human IgA with the Human Polymeric Ig Receptor
Lewis, M. J., Pleass, R. J., Batten, M. R., Atkin, J. D., & Woof, J. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6694 · Cited by 49
Self-citationSerum-free production and purification of chimeric IgA antibodies
Beyer, T. D., Lohse, S., Berger, S., Peipp, M., Valerius, T., & Dechant, M. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.05.002 · Cited by 49
Blocking Fcα Receptor I on Granulocytes Prevents Tissue Damage Induced by IgA Autoantibodies
van der Steen, L. P. E., Bakema, J. E., Sesărman, A., Florea, F., Tuk, C. W., Kirtschig, G., Hage, J. J., Sitaru, C., & van Egmond, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101763 · Cited by 48
Rouwendal, G., van der Lee, M. M., Meyer, S., Reiding, K. R., Schouten, J., de Roo, G., Egging, D. F., Leusen, J. H. W., Boross, P., Wuhrer, M., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1102812 · Cited by 48
Wines, B. D., Willoughby, N., Fraser, J. D., & Hogarth, P. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509334200 · Cited by 47
Langereis, J. D., van der Flier, M., & de Jonge, M. I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01925 · Cited by 47
Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells
Rochereau, N., Pavot, V., Verrier, B., Ensinas, A., Genin, C., Corthésy, B., & Paul, S. (2014) · European Journal of Immunology · doi:10.1002/eji.201444816 · Cited by 45
Senior, B. W., Dunlop, J. I., Batten, M. R., Kilian, M., & Woof, J. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.463-469.2000 · Cited by 44
Self-citationEngineering therapeutic antibodies to combat infectious diseases
Wagner, E. K., & Maynard, J. A. (2018) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2018.01.007 · Cited by 44
Guettinger, Y., Barbin, K., Peipp, M., Bruenke, J., Dechant, M., Horner, H., Thierschmidt, D., Valerius, T., Repp, R., Fey, G. H., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902033 · Cited by 42
Understanding rituximab function and resistance: implications for tailored therapy
Amoroso, A. (2010) · Frontiers in bioscience · doi:10.2741/3719 · Cited by 42
Wills, S., Hwang, K.-K., Liu, P., Dennison, S. M., Tay, M. Z., Shen, X., Pollara, J., Lucas, J. T., Parks, R., Rerks‐Ngarm, S., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01552-17 · Cited by 41
Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils
Pleass, R. J., Andrews, P. D., Kerr, M. A., et al. (1996) · Biochemical Journal · doi:10.1042/bj3180771 · Cited by 40
Planque, S. A., Salas, M. L., Mitsuda, Y., Sieńczyk, M., Escobar, M. A., Mooney, J. P., Morris, M. K., Nishiyama, Y., Ghosh, D., Kumar, A., et al. (2010) · AIDS · doi:10.1097/qad.0b013e3283376e88 · Cited by 39
Alternatively spliced forms of the human myeloid Fcα receptor (CD89) in neutrophils
Morton, H. C., Schiel, A. E., Janssen, S. W. J., et al. (1996) · Immunogenetics · doi:10.1007/bf00587311 · Cited by 39
Correa, A., Trajtenberg, F., Obal, G., Pritsch, O., Dighiero, G., Oppezzo, P., & Buschiazzo, A. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444912048664 · Cited by 38
Distinct Fcα receptor N-glycans modulate the binding affinity to immunoglobulin A (IgA) antibodies
Göritzer, K., Turupcu, A., Maresch, D., Novák, J., Altmann, F., Oostenbrink, C., Obinger, C., & Strasser, R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009954 · Cited by 38
Yoo, E. M., Yu, L. J., Wims, L. A., Goldberg, D. T., & Morrison, S. L. (2010) · mAbs · doi:10.4161/mabs.2.3.11802 · Cited by 37
Wang, L., Li, X., Shen, H., Mao, N., Wang, H., Cui, L., Cheng, Y., & Fan, J. (2016) · Scientific Reports · doi:10.1038/srep30964 · Cited by 37
Bakos, M. A., Kurosky, A., Czerwinski, E. W., & Goldblum, R. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1346 · Cited by 34
Excretion of Human Immunodeficiency Virus Type 1 through Polarized Epithelium by Immunoglobulin A
Wright, A., Lamm, M. E., & Huang, Y. T. (2008) · Journal of Virology · doi:10.1128/jvi.01111-08 · Cited by 34
Abi‐Rached, L., Dorighi, K. M., Norman, P. J., Yawata, M., & Parham, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7943 · Cited by 32
Deglycosylation of FcαR at N58 increases its binding to IgA
Xue, J., Zhao, Q., Zhu, L., & Zhang, W. (2010) · Glycobiology · doi:10.1093/glycob/cwq048 · Cited by 32
Alternatively spliced forms of the human myeloid Fc&; receptor (CD89) in neutrophils
Morton, H. C., Schiel, A. E., Janssen, S. W. J., et al. (1996) · Immunogenetics · doi:10.1007/s002510050057 · Cited by 31
Xu, F., Newby, J., Schiller, J. L., Schroeder, H. A., Wessler, T., Chen, A., Forest, M. G., & Lai, S. K. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00109 · Cited by 29
FcR γ-Chain Dependent Signaling in Immature Neutrophils Is Mediated by FcαRI, but Not by FcγRI
Otten, M. A., Leusen, J. H. W., Rudolph, E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2918 · Cited by 28
Hui, G. K., Wright, D. W., Vennard, O. L., Rayner, L., Pang, M., Yeo, S. C., Gor, J., Molyneux, K., Barratt, J., & Perkins, S. J. (2015) · Biochemical Journal · doi:10.1042/bj20150612 · Cited by 28
Kobayashi, T., Yamamoto, K., Sugita, N., van Spriel, A. B., Kaneko, S., van de Winkel, J. G. J., & Yoshie, H. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.2935-2942.2001 · Cited by 26
Monomeric I g A can be produced in planta as efficient as I g G , yet receives different N ‐glycans
Westerhof, L. B., Wilbers, R. H. P., van Raaij, D. R., Nguyen, D. L., Goverse, A., Henquet, M., Hokke, C. H., Bosch, D., Bakker, J., & Schots, A. (2014) · Plant Biotechnology Journal · doi:10.1111/pbi.12251 · Cited by 24
Posgai, M. T., Tonddast‐Navaei, S., Jayasinghe, M., Ibrahim, G. M., Stan, G., & Herr, A. B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807478115 · Cited by 24
The Covalent Linkage of the Secretory Component to IgA
Fallgren-Gebauer, E., Gebauer, W., Bastian, A., Kratzin, H., Eiffert, H., Zimmermann, B. K., Karas, M., & HILSCHMANN, N. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1941-6_131 · Cited by 23
Sites in the CH3 Domain of Human IgA1 That Influence Sensitivity to Bacterial IgA1 Proteases
Senior, B. W., & Woof, J. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3913 · Cited by 22
Self-citationPinheiro, A., Woof, J. M., Abi‐Rached, L., Parham, P., & Esteves, P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073934 · Cited by 20
Self-citationHeineke, M. H., van der Steen, L. P. E., Korthouwer, R., Hage, J. J., Langedijk, J. P. M., Benschop, J. J., Bakema, J. E., Slootstra, J. W., & van Egmond, M. (2017) · European Journal of Immunology · doi:10.1002/eji.201646782 · Cited by 19
Lewis, L. D., Beelen, A. P., Cole, B. F., Wallace, P. K., Fisher, J. L., Waugh, M., Kaufman, P. A., & Ernstoff, M. S. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0424-8 · Cited by 16
Watanabe, T., Kanamaru, Y., Liu, C., Suzuki, Y., Tada, N., Okumura, K., Horikoshi, S., & Tomino, Y. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04452.x · Cited by 14
Pentraxins and IgA share a binding hot‐spot on FcαRI
Lu, J., Marjon, K. D., Mold, C., Marnell, L. L., Clos, T. W. D., & Sun, P. D. (2014) · Protein Science · doi:10.1002/pro.2419 · Cited by 14
Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy
Hart, F., Danielczyk, A., & Goletz, S. (2017) · Bioengineering · doi:10.3390/bioengineering4020042 · Cited by 14
Small-Molecule Inhibitors of Haemophilus influenzae IgA1 Protease
Shehaj, L., Choudary, S. K., Makwana, K. M., Gallo, M. C., Murphy, T. F., & Kritzer, J. A. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00004 · Cited by 14
Koernig, S., Campbell, I. K., Mackenzie-Kludas, C., Schaub, A., Lötscher, M., Ng, W. C., Zehnder, R., Pelczar, P., Sanli, I., Alhamdoosh, M., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0167-z · Cited by 14
Dicker, M., Maresch, D., & Strasser, R. (2016) · Bioengineered · doi:10.1080/21655979.2016.1201251 · Cited by 13
Cited by
The pathogenesis of IgA nephropathy and implications for treatment
Cheung, C. K., Alexander, S., Reich, H. N., Selvaskandan, H., Zhang, H., & Barratt, J. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00885-3 · Cited by 222
Metadata
- Authors
- de Sousa-Pereira, P., & Woof, J. M.
- Venue
- Antibodies
- Publisher
- MDPI AG
- Published
- 2019-12-05
- Volume
- 8
- Issue
- 4
- Pages
- 57
- ISSN
- 2073-4468 (ISSN-L)
- OpenAlex
- W2992323404
- Cited by
- 264
- References
- 182
- FWCI
- 13.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.